|
|
(133 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
Zeile 1: |
Zeile 1: |
| __NOTOC__ | | __NOTOC__ |
| *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| + | |
| | | |
| *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | | |
| *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
− | {{tp|p=32020915|t=2020. The Novel Coronavirus: A Bird s Eye View |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
− | {{tp|p=32112977|t=2020. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) |pdf=|usr=}}
| + | |
− | {{tp|p=32125458|t=ä. COVID-19: a novel coronavirus and a novel challenge for critical care |pdf=|usr=}}
| + | |
| | | |
| | | |
| | | |
− | ----
| + | *'''[[Respiration mgmt]]''' |
| | | |
| + | *'''[[Diagnosis (Laboratory)]]''' |
| | | |
− | *'''[[Structure of covid19]]'''
| |
| | | |
− | *'''[[Target binding and uptake]]''' | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
− | {{tp|p=32344526|t=2020. COVID-19 and RAS: Unravelling an Unclear Relationship |pdf=|usr=}}
| + | |
| | | |
| + | *'''[[Diagnosis (other modalities)]]''' |
| | | |
| | | |
− | *'''[[Cytopathic effects]]'''
| |
| | | |
| + | |
| + | *'''[[Structure of covid19]]''' |
| + | |
| + | |
| + | *'''[[Target binding and uptake]]''' |
| + | *'''[[Cytopathic effects]]''' |
| *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| + | |
| + | |
| | | |
| *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
Zeile 30: |
Zeile 36: |
| | | |
| *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
− | {{tp|p=32334118|t=ä. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 |pdf=|usr=}}
| |
| | | |
| | | |
− | ----
| |
| | | |
| + | *'''[[Pathobiology]]''' |
| | | |
− | *'''[[Early symptoms]]'''
| |
| | | |
− | *'''[[Systemic disease, any manifestations]]''' | + | *'''[[Disease Models]]''' |
| | | |
− | *'''[[Co-Infection]]'''
| |
| | | |
− | *'''[[ARDS]]''' | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | |
− | *'''[[Pulmonary embolism, coagulation]]'''
| |
| | | |
| | | |
− | *'''[[Hematology]]'''
| |
| | | |
− | *'''[[Microvascular]]''' | + | *'''[[Early symptoms]]''' |
| | | |
− | *'''[[Heart]]''' | + | *'''[[Systemic disease, any manifestations]]''' |
| | | |
− | *'''[[Neurology, ophthalmology, orl]]''' | + | *'''[[Co-Infection]]''' |
− | {{tp|p=32251791|t=2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 |pdf=|usr=}}
| + | |
− | {{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}}
| + | |
| | | |
| | | |
− | *'''[[Dermatology]]''' | + | *'''[[Pulmonary embolism, coagulation]]''' |
| | | |
− | *'''[[Gastroenterology, hepatology]]'''
| |
| | | |
− | *'''[[Kidney, urology]]'''
| |
| | | |
− | ----
| |
| | | |
| | | |
− | *'''[[Pathobiology]]''' | + | *'''[[Hematology]]''' |
− | {{tp|p=32094336|t=2020. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa |pdf=|usr=}}
| + | |
| | | |
| | | |
− | *'''[[Disease Models]]'''
| |
| | | |
− | *'''[[Similar diseases and pathomechanisms]]''' | + | *'''[[Heart]]''' |
− | ----
| + | |
| | | |
| | | |
− | *'''[[Diagnosis (Laboratory)]]'''
| |
− | {{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
| |
| | | |
| + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | |
| | | |
− | *'''[[Diagnosis (Lung CT, Sonography)]]'''
| |
| | | |
| + | *'''[[Dermatology]]''' |
| | | |
| | | |
| | | |
− | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[Gastroenterology, hepatology]]''' |
− | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | |
| + | *'''[[Kidney, urology]]''' |
| | | |
− | *'''[[Respiration mgmt]]''' | + | *'''[[The morbid survivor]]''' |
− | {{tp|p=32251794|t=2020. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?|pdf=|usr=}}
| + | |
| | | |
| + | *'''[[Risk and special populations]]''' |
| | | |
− | *'''[[Clinical guidelines and advice]]'''
| |
| | | |
− | *'''[[Risk and special populations]]''' | + | |
− | {{tp|p=32355869|t=ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?|pdf=|usr=}}
| + | *'''[[Case reports]]''' |
− | {{tp|p=32222883|t=ä. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection |pdf=|usr=}}
| + | |
− | {{tp|p=32125452|t=ä. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China |pdf=|usr=}}
| + | |
| | | |
| | | |
| | | |
| | | |
− | *'''[[The morbid survivor]]'''
| |
| | | |
| | | |
− | *'''[[Case reports]]'''
| |
| | | |
| *'''[[Case series]]''' | | *'''[[Case series]]''' |
Zeile 114: |
Zeile 101: |
| | | |
| *'''[[Registries]]''' | | *'''[[Registries]]''' |
− | ----
| |
| | | |
| | | |
| *'''[[Trials]]''' | | *'''[[Trials]]''' |
− | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
− | {{tp|p=32368489|t=2020. The pathogenesis and alternative treatment of SARS-CoV2 |pdf=|usr=}}
| |
− | {{tp|p=32289016|t=2020. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines |pdf=|usr=}}
| |
− | {{tp|p=32125455|t=ä. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |pdf=|usr=}}
| |
− | {{tp|p=32347443|t=ä. Camostat mesilate therapy for COVID-19 |pdf=|usr=}}
| |
| | | |
| | | |
− | | + | *'''[[Other routes of infection]]''' |
− | ----
| + | |
| | | |
| | | |
| *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
− | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| | | |
− | *'''[[Other routes of infection]]'''
| |
− | {{tp|p=32335340|t=ä. Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health |pdf=|usr=}}
| |
| | | |
− |
| |
− |
| |
− | *'''[[Remission, recurrence and persistence]]'''
| |
− | {{tp|p=32200109|t=2020. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge |pdf=|usr=}}
| |
− | {{tp|p=32251796|t=ä. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?|pdf=|usr=}}
| |
− | {{tp|p=32147538|t=2020. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
− | {{tp|p=32325718|t=2020. Personal Safety during the COVID-19 Pandemic: Realities and Perspectives of Healthcare Workers in Latin America |pdf=|usr=}}
| |
− | {{tp|p=32334119|t=ä. Addressing the corona virus outbreak: will a novel filtered eye mask help?|pdf=|usr=}}
| |
− | {{tp|p=32203757|t=2020. Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19) |pdf=|usr=}}
| |
− | {{tp|p=32265088|t=ä. Custom-made 3D-printed face masks in case of pandemic crisis situations with a lack of commercially available FFP2/3 masks |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 157: |
Zeile 123: |
| | | |
| | | |
| + | *'''[[Mental aspects of health professionals]]''' |
| | | |
− | ---- | + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | |
| | | |
− | *'''[[Mental aspects of health professionals]]'''
| |
| | | |
− |
| |
− | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| | | |
| *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| + | |
| + | |
| | | |
| *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| + | |
| | | |
| *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
− | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
− | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| | | |
| | | |
Zeile 180: |
Zeile 145: |
| | | |
| *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
− |
| |
| | | |
| *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| | | |
| *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
− | {{tp|p=32225178|t=2020. The Impact of COVID-19 on Italy: A Lesson for the Future |pdf=|usr=}}
| |
− | {{tp|p=32218558|t=2020. Preparedness and Lessons Learned from the Novel Coronavirus Disease |pdf=|usr=}}
| |
− | {{tp|p=32271914|t=ä. The hearth of mathematical and statistical modelling during the Coronavirus pandemic |pdf=|usr=}}
| |
− | {{tp|p=32123989|t=ä. The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges |pdf=|usr=}}
| |
| | | |
| | | |
| | | |
− | *'''[[Failure of politics and public health guidance]]''' | + | |
| + | |
| + | *'''[[Remission, recurrence and persistence]]''' |
| + | |
| + | |
| | | |
| *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| ---- | | ---- |
| + | *'''[[Failure of politics and public health guidance]]''' |
| | | |
| | | |
| *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
− | {{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
| + | |
− | *[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
| + | |
| | | |
| | | |
| *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
− | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| | | |
| *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| + | |
| ---- | | ---- |
| | | |
| | | |
| *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
− |
| |
| *'''[[misc.]]''' | | *'''[[misc.]]''' |
− | {{tp|p=32175070|t=2020. Positive Screening for Wuhan Novel Coronavirus Infection at International Airport: What s the Final Diagnosis for Positive Cases |pdf=|usr=}}
| |
− | {{tp|p=32372270|t=ä. Three further ways that the COVID-19 pandemic will affect health outcomes |pdf=|usr=}}
| |
− | {{tp|p=32307030|t=ä. The fight against COVID-19: a report from the Italian trenches |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| + | |
| + | |
| + | |
| + | |
| + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| + | |
| + | |
| + | *'''[[PrePrint scene]]''' |
| + | |
| | | |
| *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| | | |
| *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| + | *'''[[on-topic personal thoughts]]''' |